55
Views
2
CrossRef citations to date
0
Altmetric
Articles

Liver tumor potency indicators for technical toxaphene and congeners simulating weathered toxaphene

, , &
Pages 830-846 | Received 13 Oct 2017, Accepted 02 Nov 2017, Published online: 22 Dec 2017

References

  • Aasen T, Mesnil M, Naus CC, Lampe PD, Laird DW. 2016. Gap junctions and cancer: Communicating for 50 years. Nat Rev Cancer 16:775–88
  • Baker TK, Bachowski S, Stevenson DE, Walborg EF, Klaunig JE. 1995. Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. Prog Clin Biol Res 391:71–80
  • Besselink H, Nixon E, McHugh B et al., 2008. Evaluation of tumour promoting potency of fish borne toxaphene residues, as compared to technical toxaphene and UV-irradiated toxaphene. Food Chem Toxicol 46:2629–38
  • Davidson JS, Baumgarten IM, Harley EH. 1985. Studies on the mechanism on phorbol ester-induced inhibition of intercellular junctional communication. Carcinogenesis 6:1353–58
  • Ekici P, Friess A, Parlar H. 2008. Permissible level of toxaphene in fish from German market based on in vivo and in vitro effects to tumor promotion. Food Chem Toxicol 46:2322–25
  • Elcombe CR, Peffer RC, Wolf DC et al., 2014. Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 44:64–82
  • EPA. 1988. Integrated Risk Information System profile for Toxaphene. U.S. Environmental Protection Agency (EPA), Washington, DC. Available at: https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0346_summary.pdf
  • EPA. 1990. Notice of intent to remove certain active ingredients from reregistration list B and to cancel pesticides containing those ingredients. U.S. Environmental Protection Agency (EPA). Federal Register. 55 FR 31164–74
  • EPA IRIS. 2017. Integrated Risk Information System profiles for Aldrin, Dieldrin and Chlordane. U.S. Environmental Protection Agency (EPA), Integrated Risk Information System (IRIS), Washington, DC. Available at: https://cfpub.epa.gov/ncea/iris/search/index.cfm?keyword=toxaphene
  • Falk MM, Bell CL, Kells Andres RM, Murray SA. 2016. Molecular mechanisms regulating formation, trafficking and processing of annular gap junctions. BMC Cell Biol 17 (Suppl 1):22. doi:10.1186/s12860-016-0087-7
  • Goodman JI, Brusick DJ, Busey WM et al., 2000. Reevaluation of the cancer potency factor of toxaphene: Recommendations from a peer review panel. Toxicol Sci 55:3–16
  • Hedli CC, Snyder R, Kinoshita FK, Steinberg M. 1998. Investigation of hepatic cytochrome P-450 enzyme induction and DNA adduct formation in male CD/1 mice following oral administration of toxaphene. J Appl Toxicol 18:173–8
  • Holder JW, Elmore E, Carl Barrett J. 1993. Gap junction function and cancer. Cancer Res 53:3475–85
  • Holsapple MP, Pitot HC, Cohen SM et al., 2006. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci 89:51–6
  • Jansson B, Wideqvist U. 1983. Analysis of toxaphene (PCC) and chlordane in biological samples by NCI mass spectrometry. Int J Environ Anal Chem 13:309–21
  • Kang KS, Wilson MR, Hayashi T, Chang CC, Trosko JE. 1996. Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ Health Perspect 104(2):192–200
  • Kazantseva YA, Pustylnyak YA, Pustylnyak VO. 2016. Role of nuclear constitutive androstane receptor in regulation of hepatocyte proliferation and hepatocarcinogenesis. Biochemi (Moscow) 81(4):338–47
  • Kerger BD, Bogen KT, Loccisano AE, Lamb JC. 2017. Proposed reference dose for toxaphene carcinogenicity based on constitutive androstane receptor-mediated mode of action. Hum Ecol Risk Assess (in press).
  • Klaunig JE, Goldblatt PJ, Hinton DE, et al. 1981. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 17:913–25
  • Klaunig JE, Ruch RJ. 1987. Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters. Cancer Lett 36:161–68
  • Klaunig JE. 1991. Alterations in intercellular communication during the stage of promotion. Gap junctions and hepatic tumor promotion. Proc Soc Exp Biol Med 198:688–92
  • Kitano M, Ichihara T, Matsuda T, et al. 1998. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis 19:1475–80
  • Kjenseth A, Fykerud T, Rivedal E, Leither E. 2010. Regulation of gap junction intercellular communication by the ubiquitin system. Cell Signalling 22:1267–73
  • Lamb JC, Neal BH, Goodman JI. 2008. Risk assessment of toxaphene and its breakdown products: Time for a change? Crit Rev Toxicol 38:805–15
  • Lamb JC, Walker CL, Neal BH, Klaunig JE. 2010. Inhibition of Gap Junction Intercellular Communication (GJIC) in mouse liver cells by technical toxaphene and toxaphene congeners. Toxicol Sci 114:228, Abstract 525
  • LeBaron MJ, Gollapudi BB, Terry C, Billington R, Rasoulpour RJ. 2014. Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor. Crit Rev Toxicol 44(Suppl 2):15–24
  • Leonards PE, Besselink H, Klungsoyr J, et al. 2012. Toxicological risks to humans of toxaphene residues in fish. Integr Environ Assess Manag 8:523–9
  • Li D, Mackowiak B, Brayman TG, et al. 2015. Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells. Biochem Pharmacol 98(1):190–202
  • Li L, Bao X, Zhang Q-Y, Negishi M, Ding X. 2017. Role of CYP2B in phenobarbital-induced hepatocyte proliferation in mice. Drug Metab Disposit. 45(8):977–981. doi:10.1124/dmd.117.076406
  • Maruya KA, Wakeham SG, Vetter W, Francendese L. 2000. Prominent chlorobornane residues in estuarine sediments contaminated with toxaphene. Environ Toxicol Chem 19:2198–203
  • MATT. 2000. Monitoring, Analysis and Toxicity of Toxaphene in Marine Foodstuffs. European Union, Brussels, Final Report: FAIR CT PL.96.3131
  • McClain RM. 1990. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital. Prog Clin Biol Res 331:345–65
  • McHugh B, Glynn D, Nixon E, McGovern E. 2003. The occurrence and risk assessment of the pesticide toxaphene in fish from Irish waters. Mar Environ Health Ser 12:1–32
  • NCBI. 2017. PubChem BioAssay Database; AID = 1224839. U.S. Library of Medicine, National Center for Biotechnology Information (NCBI), Bethesda, MD. Available at: https://pubchem.ncbi.nlm.nih.gov/bioassay/1224839. Accessed Aug. 12, 2017
  • NCI. 1979. Bioassay of Toxaphene of Possible Carcinogenicity. Technical Report Series No. 37. National Cancer Institute (NCI), Washington, DC
  • Parlar H. 2006. Commentary on toxaphene as it degrades in the environment Fresenius. Environ Bull 15:1330–5
  • Pulster EL, Smalling KL, Zolman E, Schwacke L, Maruya KA. 2009. Persistent organochlorine pollutants and toxaphene congener profiles in bottlenose dolphins (Tursiops truncatus) frequenting the Turtle/Brunswick River Estuary (TBRE) in coastal Georgia, USA Environ Toxicol Chem 28:1390–99
  • Pu X, Kamendulis LM, Klaunig JE. 2006. Acrylonitrile induces oxidative DNA damage in rat astrocytes. Environ Mol Mutagen 47:631–8
  • Rignall B, Braeuning A, Buchmann A, Schwarz M. 2011. Tumor formation in liver of conditional beta-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen. Carcinogenesis 32:52–7
  • Rivedal E, Opsahl H. 2001. Role of PKC and MAP kinase in EGF- and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogenesis 22:1543–50
  • Ross J, Plummer SM, Rode A, et al. 2010. Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci 116(2):452–66
  • Ruch RJ, Klaunig JE. 1988. Kinetics of phenobarbital inhibition of intercellular communication in mouse hepatocytes. Cancer Res 48:2519–23
  • Ruch RJ, Trosko JE. 2001. Gap-junction communication in chemical carcinogenesis. Drug Metab Rev 33:117–24
  • Ruppe S, Neumann A, Braekevelt E, et al. 2004. Anaerobic transformation of compounds of technical toxaphene. 2. Fate of compounds lacking geminal chlorine atoms. Environ Toxicol Chem 23:591–8
  • Ruppe S, Neumann A, Vetter W. 2003. Anaerobic transformation of compounds of technical toxaphene. I. Regiospecific reaction of chlorobornanes with geminal chlorine atoms. Environ Toxicol Chem 22:2614–21
  • Schwarz M, Wanke I, Wulbrand U, Moennikes O, Buchmann A. 2003. Role of connexin32 and beta-catenin in tumor promotion in mouse liver. Toxicol Pathol 31(1):99–102
  • Sigler K, Ruch RJ. 1993. Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer Lett 69:15–9
  • Simon T, Manning R. 2006. Development of a reference dose for the persistent congeners of weathered toxaphene based on in vivo and in vitro effects related to tumor promotion. Regul.Toxicol.Pharmacol 44:268–81
  • Sirnes S, Kjenseth A, Leither E, Rivedal E. 2009. Interplay between PKC and the MAP kinase pathway in Connexin43 phosphorylation and inhibition of gap junction intercellular communication. Biochem Biophys Res Comm 382:41–5
  • Trosko JE, Jone C, Chang CC. 1987. Inhibition of gap junctional-mediated intercellular communication in vitro by aldrin, dieldrin and toxaphene: a possible cellular mechanism for their tumor-promoting and neurotoxic effects. Mol Toxicol 1:83–93
  • Wang Z, Li X, Wu Q, Lamb JC, Klaunig JE. 2017. Toxaphene-induced mouse liver tumorigenesis is mediated by the constitutive androstane receptor. J Appl Toxicol 37:967–75
  • Wang Z, Neal BH, Lamb JC, Klaunig JE. 2015. Mechanistic investigation of toxaphene induced mouse liver tumors. Toxicol Sci 147:549–61
  • Warner KA, Fernstrom MJ, Ruch RJ. 2003. Inhibition of mouse hepatocyte gap junctional intercellular communication by phenobarbital correlates with strain-specific hepatocarcinogenesis. Toxicol Sci 71:190–7
  • Westfall PH, Tobias RD, Wolfinger RD. 2011. Multiple Comparisons and Multiple Tests Using SAS. 2nd ed. Institute SAS, Cary, North Carolina, USA.
  • Whysner J, Ross PM, Williams GM. 1996. Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:153–91
  • Wolfram Research. 2017. Wolfram Language and System Documentation Center. Wolfram Research, Inc., Champaign, IL (www.wolfram.com), http://reference.wolfram.com/language/
  • Yamasaki H. 1990. Gap junctional intercellular communication and carcinogenesis Carcinogenesis. 11:1051–8
  • Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V. 1995. Intercellular communication and carcinogenesis. Mutat Res 333:181–8
  • Young JC, Freeman AD, Bruce RM, Williams D, Maruya K. 2009. Comparing the mutagenicity of toxaphene after aging in anoxic soils and accumulating in fish. Ecotoxicol Environ Saf 72:162–72

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.